Inventor · disambiguated record
Taehwan Kwak
Also filed as: KWAK TAEHWAN
4 granted patents·16 pending applications·12 citations·filing 2004–2013
70Inventor score
Top patents by PatentIndex Score
20 records- 0178US9066922B2Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseasesMD BIOALPHA CO LTD·Filed 2013·Granted Jun 30, 2015·5 cites·6 claims
- 0278US8466141B2Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseasesYOO SANG-KU·Filed 2009·Granted Jun 18, 2013·4 cites·5 claims
- 0373US8029832B2Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activityMD BIOALPHA CO LTD·Filed 2009·Granted Oct 4, 2011·3 cites·8 claims
- 0456US2010062065A1Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery systemMAZENCE INC·Filed 2007·Application pending·0 cites
- 0556US2010234453A1Pharmaceutical composition containing phenanthrenequinone-based compound for intestine delivery systemJO IN GEUN·Filed 2007·Application pending·0 cites
- 0655US2010239685A1Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the sameKWAK TAEHWAN·Filed 2007·Application pending·0 cites
- 0755US2009215145A1Method for controlling nad(p)/nad(p)h ratio by oxidoreductaseMD BIOALPHA CO LTD·Filed 2007·Application pending·0 cites
- 0855US2010255054A1Pharmaceutical composition for treatment and prevention of restenosisKWAK TAEHWAN·Filed 2007·Application pending·0 cites
- 0954US2014106387A1Method for controlling nad(p)/nad(p)h ratio by oxidoreductaseMD BIOALPHA CO LTD·Filed 2013·Application pending·0 cites
- 1051US2010239674A1Pharmaceutical composition for the treatment and prevention of diseases involving impotenceKWAK TAEHWAN·Filed 2007·Application pending·0 cites
- 1150US2011002995A1Pharmaceutical composition for the treatment and prevention of cardiac diseaseMAZENCE INC·Filed 2008·Application pending·0 cites
- 1250US2008146655A1Pharmaceutical Composition for the Treatment or Prevention of Diseases Involving Obesity, Diabetes, Metabolic Syndrome, Neuro-Degenerative Diseases and Mitochondria Dyfunction DiseasesMD BIOALPHA CO LTD·Filed 2006·Application pending·0 cites
- 1346US2012114714A1Method for the treatment and prevention of erectile dysfunctionKWAK TAEHWAN·Filed 2012·Application pending·0 cites
- 1445US2010310657A1Pharmaceutical composition for treatment and prevention of kidney diseasesMAZENCE INC·Filed 2008·Application pending·0 cites
- 1544US2014154319A1Pharmaceutical composition for the treatment and prevention of cardiac diseaseKWAK TAEHWAN·Filed 2013·Application pending·0 cites
- 1643US8404869B2Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndromeYOO SANG-KU·Filed 2008·Granted Mar 26, 2013·0 cites·15 claims
- 1742US2010209513A1Pharmaceutical composition containing micronized particles of naphthoquinone-based compoundJO IN GEUN·Filed 2008·Application pending·0 cites
- 1842US2007248698A1Obesity and Metabolic Syndrome Treatment with Tanshinone Derivatives Which Increase Metabolic ActivityKT & G CO LTD·Filed 2004·Application pending·0 cites
- 1941US2013302422A1Pharmaceutical composition for treatment and prevention of kidney diseasesKT & G CORP·Filed 2013·Application pending·0 cites
- 2037US2011020448A1Pharmaceutical composition for the treatment and prevention of glaucomaMAZENCE INC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Taehwan Kwak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →